These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 7850795

  • 1. Expression of the messenger RNAs for luteinizing hormone-releasing hormone (LHRH) and its receptor in human ovarian epithelial carcinoma.
    Irmer G, Bürger C, Müller R, Ortmann O, Peter U, Kakar SS, Neill JD, Schulz KD, Emons G.
    Cancer Res; 1995 Feb 15; 55(4):817-22. PubMed ID: 7850795
    [Abstract] [Full Text] [Related]

  • 2. High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines.
    Emons G, Ortmann O, Becker M, Irmer G, Springer B, Laun R, Hölzel F, Schulz KD, Schally AV.
    Cancer Res; 1993 Nov 15; 53(22):5439-46. PubMed ID: 8221683
    [Abstract] [Full Text] [Related]

  • 3. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase.
    Gründker C, Völker P, Emons G.
    Endocrinology; 2001 Jun 15; 142(6):2369-80. PubMed ID: 11356684
    [Abstract] [Full Text] [Related]

  • 4. Luteinizing hormone-releasing hormone induces JunD-DNA binding and extends cell cycle in human ovarian cancer cells.
    Günthert AR, Gründker C, Hollmann K, Emons G.
    Biochem Biophys Res Commun; 2002 May 31; 294(1):11-5. PubMed ID: 12054733
    [Abstract] [Full Text] [Related]

  • 5. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers.
    Gründker C, Völker P, Schulz KD, Emons G.
    Gynecol Oncol; 2000 Aug 31; 78(2):194-202. PubMed ID: 10926802
    [Abstract] [Full Text] [Related]

  • 6. Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium.
    Imai A, Ohno T, Iida K, Fuseya T, Furui T, Tamaya T.
    Gynecol Oncol; 1994 Oct 31; 55(1):144-8. PubMed ID: 7959256
    [Abstract] [Full Text] [Related]

  • 7. Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop.
    Dondi D, Limonta P, Moretti RM, Marelli MM, Garattini E, Motta M.
    Cancer Res; 1994 Aug 01; 54(15):4091-5. PubMed ID: 8033142
    [Abstract] [Full Text] [Related]

  • 8. Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonadotropins in human immortalized ovarian surface epithelium and ovarian cancer cells.
    Choi JH, Choi KC, Auersperg N, Leung PC.
    Endocr Relat Cancer; 2006 Jun 01; 13(2):641-51. PubMed ID: 16728589
    [Abstract] [Full Text] [Related]

  • 9. Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system.
    Günthert AR, Gründker C, Bongertz T, Schlott T, Nagy A, Schally AV, Emons G.
    Am J Obstet Gynecol; 2004 Oct 01; 191(4):1164-72. PubMed ID: 15507937
    [Abstract] [Full Text] [Related]

  • 10. Differential inhibitory effects on human endometrial carcinoma cell growth of luteinizing hormone-releasing hormone analogues.
    Borri P, Coronnello M, Noci I, Pesciullesi A, Peri A, Caligiani R, Maggi M, Torricelli F, Scarselli G, Chieffi O, Mazzei T, Mini E.
    Gynecol Oncol; 1998 Dec 01; 71(3):396-403. PubMed ID: 9887238
    [Abstract] [Full Text] [Related]

  • 11. Receptors for luteinizing hormone releasing hormone expressed on human renal cell carcinomas can be used for targeted chemotherapy with cytotoxic luteinizing hormone releasing hormone analogues.
    Keller G, Schally AV, Gaiser T, Nagy A, Baker B, Halmos G, Engel JB.
    Clin Cancer Res; 2005 Aug 01; 11(15):5549-57. PubMed ID: 16061872
    [Abstract] [Full Text] [Related]

  • 12. Expression of luteinizing hormone releasing hormone and its mRNA in human endometrial cancer cell lines.
    Irmer G, Bürger C, Ortmann O, Schulz KD, Emons G.
    J Clin Endocrinol Metab; 1994 Sep 01; 79(3):916-9. PubMed ID: 8077383
    [Abstract] [Full Text] [Related]

  • 13. Effective treatment of experimental human endometrial cancers with targeted cytotoxic luteinizing hormone-releasing hormone analogues AN-152 and AN-207.
    Engel JB, Keller G, Schally AV, Nagy A, Chism DD, Halmos G.
    Fertil Steril; 2005 Apr 01; 83 Suppl 1():1125-33. PubMed ID: 15831285
    [Abstract] [Full Text] [Related]

  • 14. Luteinizing hormone-releasing hormone (LHRH) inhibits apoptosis induced by cytotoxic agent and UV-light but not apoptosis mediated through CD95 in human ovarian and endometrial cancer cells.
    Günthert AR, Gründker C, Böttcher B, Emons G.
    Anticancer Res; 2004 Apr 01; 24(3a):1727-32. PubMed ID: 15274347
    [Abstract] [Full Text] [Related]

  • 15. Increased incidence of luteinizing hormone-releasing hormone receptor gene messenger RNA expression in hormone-refractory human prostate cancers.
    Straub B, Müller M, Krause H, Schrader M, Goessl C, Heicappell R, Miller K.
    Clin Cancer Res; 2001 Aug 01; 7(8):2340-3. PubMed ID: 11489810
    [Abstract] [Full Text] [Related]

  • 16. High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers.
    Halmos G, Arencibia JM, Schally AV, Davis R, Bostwick DG.
    J Urol; 2000 Feb 01; 163(2):623-9. PubMed ID: 10647698
    [Abstract] [Full Text] [Related]

  • 17. [Construction and expression of recombinant cecropin B-binding site of luteinizing hormone releasing hormone gene and its anticancer function].
    Li XY, Li HL, Zheng GY.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul 01; 42(7):477-81. PubMed ID: 17961339
    [Abstract] [Full Text] [Related]

  • 18. Expression of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor mRNAs in various non-reproductive human tissues.
    Kakar SS, Jennes L.
    Cancer Lett; 1995 Nov 27; 98(1):57-62. PubMed ID: 8529206
    [Abstract] [Full Text] [Related]

  • 19. The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer, and its relevance as an autocrine growth factor.
    Chatzaki E, Bax CM, Eidne KA, Anderson L, Grudzinskas JG, Gallagher CJ.
    Cancer Res; 1996 May 01; 56(9):2059-65. PubMed ID: 8616851
    [Abstract] [Full Text] [Related]

  • 20. Human malignant melanomas express receptors for luteinizing hormone releasing hormone allowing targeted therapy with cytotoxic luteinizing hormone releasing hormone analogue.
    Keller G, Schally AV, Gaiser T, Nagy A, Baker B, Westphal G, Halmos G, Engel JB.
    Cancer Res; 2005 Jul 01; 65(13):5857-63. PubMed ID: 15994963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.